Jasper Therapeutics, Inc.

JSPR · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 22 employees
126
SEC Filings
$0.829
Close 2026-05-29
22
Employees

Business Summary

PART I Overview We are a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma and we continue to consider additional indications in mast cell driven diseases for potential future development. We have also historically explored development programs in diseases where targeting diseased hemopoietic stem cells can provide benefits, such as stem cell trans...

Latest Stock Quote

JSPR 2026-05-29 $0.829 O:$0.909 H:$0.9143 L:$0.8201 Vol:0.3M VWAP:$0.8537
origin leaf: b5d78e4b80f20904037a1e713549c4b4c2a7f1bb1b1a612aec69f4a276ba5a8f

Next Earnings

Q2 FY2026 — expected 2026-09-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001213900-26-036426EDGAR99K words
2025-02-282024-12-310001213900-25-018384EDGAR—
2024-03-052023-12-310001213900-24-020114EDGAR—
2023-03-082022-12-310001213900-23-018542EDGAR—
2022-03-182021-12-310001213900-22-013592EDGAR—
2021-03-302020-12-310001213900-21-018735EDGAR—
2020-03-262019-12-310001213900-20-007505EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001213900-25-107884EDGAR39K words
2025-08-132025-06-300001213900-25-075635EDGAR—
2025-05-122025-03-310001213900-25-042011EDGAR—
2024-11-072024-09-300001213900-24-095173EDGAR—
2024-08-132024-06-300001213900-24-067897EDGAR—
2024-05-142024-03-310001213900-24-042805EDGAR—
2023-11-092023-09-300001213900-23-084970EDGAR—
2023-08-112023-06-300001213900-23-066234EDGAR—
2023-05-122023-03-310001213900-23-039021EDGAR—
2022-11-102022-09-300001213900-22-071165EDGAR—
2022-08-122022-06-300001213900-22-047382EDGAR—
2022-05-122022-03-310001213900-22-025945EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001213900-26-036448EDGAR3K words
2026-01-080001213900-26-002329EDGAR—
2026-01-070001213900-26-002185EDGAR—
2025-12-020001213900-25-116943EDGAR—
2025-11-100001213900-25-107874EDGAR—
2025-09-190001213900-25-089584EDGAR—
2025-08-130001213900-25-075678EDGAR—
2025-07-090001213900-25-062194EDGAR—
2025-07-070001213900-25-061632EDGAR—
2025-07-030001213900-25-061471EDGAR—

126 total filings indexed. 97 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001788028
TickerJSPR
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.jaspertherapeutics.com
Listed2021-09-27

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 09787085b4719f52baee4690f1dba405f0e8336ac878e39546e78145d6a66dba
parent: 67f9f93fa85e0a83e920c2499f39a013330ad04ab62616c6f26d3cba64024d0a
content hash: 7378abe2fa4334131b05c6f8f18aab20352170ecda71d8320b08e974c80669ef
signed: 2026-06-02T19:01:36.470Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf